All relevant data are within the paper and its Supporting Information files.

Introduction {#sec005}
============

Intellectual disability (ID) or mental retardation (MR) is a developmental disability characterized by significant limitations in both intellectual functioning and adaptive behavior. Its onset occurs before 18 years of age\[[@pone.0153655.ref001]\], and its prevalence in the general population has been estimated at more than 1/100\[[@pone.0153655.ref002]\]. ID can be classified as genetic or non-genetic depending on its etiology. The causes of genetic ID, which accounts for only 30% to 50% of all ID cases\[[@pone.0153655.ref003]\], include chromosomal abnormalities (e.g. trisomy 21 syndrome), inherited genetic traits (e.g. fragile X syndrome) and single gene disorders (e.g. Prader---Willi syndrome)\[[@pone.0153655.ref004], [@pone.0153655.ref005]\]. However, the causes of non-genetic ID are not fully known. It is now suggested that the risk factors for non-genetic ID are extensive, and can be classified as prenatal, perinatal and neonatal factors according to the timing of suffering.

Numerous population-based studies have focused on specific non-genetic exposures as possible risk factors for ID. Many support the hypothesis that some prenatal (e.g. increasing maternal age, multiple gestation and maternal hypertension), perinatal (e.g. preterm birth and fetal distress) and neonatal (e.g. male sex, low birth weight and neonatal infection) exposures may increase the risk of ID\[[@pone.0153655.ref006], [@pone.0153655.ref007]\]. However, the overall conclusions of these studies are inconsistent. For example, some studies found that maternal hypertension increased the risk of ID\[[@pone.0153655.ref008], [@pone.0153655.ref009]\], whereas others did not\[[@pone.0153655.ref010]--[@pone.0153655.ref012]\]. The aim of the present study was to perform a meta-analysis of all pertinent available data to determine whether prenatal, perinatal, and neonatal exposures affect the onset of ID.

Material and Methods {#sec006}
====================

Study identification and selection {#sec007}
----------------------------------

The study was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses criteria (PRISMA) as shown in [S1 File](#pone.0153655.s001){ref-type="supplementary-material"}. The PubMed and Embase databases were searched using following keywords and subject terms: "intellectual disability", "mental retardation", "ID", "MR" in combination with "prenatal", "pregnancy", "obstetric", "perinatal", "neonatal". The last search was updated on September 15, 2015. There was no language restriction. All studies were initially screened by reading the titles and abstracts, and the full-texts of potential studies were independently assessed for eligibility by two reviewers (Jichong Huang and Tingting Zhu), who discussed disagreements to reach a consensus.

To be included in our analysis, the study had to: (1) evaluate the association between prenatal, perinatal, or neonatal factors and risk of ID, (2) have a cohort, case-control, or cross-sectional design, and (3) report odds ratios (ORs) and corresponding 95% confidence intervals (CIs) or other usable data. Studies were excluded if they: (1) did not eliminate the impact of genetic causes (e.g,. trisomy 21 syndrome, Prader-Willi syndrome and fragile X syndrome) on the risk of ID, (2) did not include a control group, or (3) overlapped with another study.

Data extraction {#sec008}
---------------

The following data were independently collected by two reviewers (Jichong Huang and Tingting Zhu) from each of the included studies: name of the first author, year of publication, the country in which the study was conducted, study design, age at diagnosis, total number of cases and controls, exposure assessment methods, outcome assessment methods, ID diagnostic criteria, and risk factors.

We only included risk factors that were evaluated in two or more studies. For each risk factor, we extracted the OR together with the 95% CI. When the OR was not provided in the study, we computed a crude OR.

Quality assessment {#sec009}
------------------

The methodological quality of each included study was independently assessed by two reviewers (Jichong Huang and Tingting Zhu) using the Newcastle-Ottawa Scale (NOS)\[[@pone.0153655.ref013], [@pone.0153655.ref014]\]. The quality score was evaluated based on three categories: group selection (four items), comparability between groups (one item), and outcome and exposure assessment (three items). And the maximum score was nine points. Studies were considered to be of high quality if they were scored above the median (\> five points). Disagreements between the two reviewers were discussed until a consensus was reached.

Statistical analysis {#sec010}
--------------------

A separate meta-analysis was conducted for each risk factor and the pooled OR was calculated by using the fixed-effects model (a P-value \>0.10 indicated heterogeneity) or the random-effects model (a P-value \<0.10 indicated heterogeneity) \[[@pone.0153655.ref015], [@pone.0153655.ref016]\]. Heterogeneity among studies was assessed by using the chi-square and I^2^ tests. Data were considered statistically heterogeneous if I^2^ \>50% and P was \<0.1. Publication bias was assessed by conducting tests for funnel plot asymmetry\[[@pone.0153655.ref017]\]. Begg's test\[[@pone.0153655.ref018]\] and Egger's test\[[@pone.0153655.ref019]\] were also used to assess publication bias. The statistical tests were performed by using Review Manager 5.3 and STATA 12.0 software.

Results {#sec011}
=======

Study selection and characteristics {#sec012}
-----------------------------------

A total of 1,263 studies (927 in PubMed and 336 in Embase) and an additional eight studies culled from other sources were identified after an initial search. After reading the titles and abstracts, 1227 studies were excluded for irrelevant to the prenatal, perinatal or neonatal factors and ID risk, and five studies were excluded because of duplication. After reading the full-texts of the remaining 39 studies, 22 studies were excluded because they did not assess the effect of genetic causes on the risk of ID (13 studies), did not include a control group (six studies), or lacked usable data (three studies). Consequently, our analysis ultimately included 17 studies with a total of 55,344 patients and 5,723,749 control individuals. The meta-analysis included 15 risk factors (12 prenatal, one perinatal, and two neonatal). The selection process is shown in [Fig 1](#pone.0153655.g001){ref-type="fig"}, and the characteristics of each included study are presented in [Table 1](#pone.0153655.t001){ref-type="table"}.

![Flow gram of study selection process.](pone.0153655.g001){#pone.0153655.g001}

10.1371/journal.pone.0153655.t001

###### Characteristics of the included studies in meta-analysis.

![](pone.0153655.t001){#pone.0153655.t001g}

  First author                                                    Year   Country       Number(case/control)   Age of diagnosis   Study design                 Exposure assessment                 Outcome assessment                            ID diagnostic criteria
  --------------------------------------------------------------- ------ ------------- ---------------------- ------------------ ---------------------------- ----------------------------------- --------------------------------------------- -------------------------------------
  Onicescu, G\[[@pone.0153655.ref020]\]                           2014   USA           420/6859               6--11              Retrospective cohort study   Medical Record                      Medical and school records                    ICD9
  Mann, JR\[[@pone.0153655.ref021]\]                              2013   USA           3113/75562             3--6               Retrospective cohort study   Medical Record                      Registration data                             ICD9
  Bilder, DA\[[@pone.0153655.ref011]\]                            2013   USA           146/16936              8                  Case-control study           Birth Certificate                   School and health records                     ICD9
  O\'Leary, C \[[@pone.0153655.ref022]\](Non-Aboriginal births)   2013   Australia     10576/30744            0--6               Retrospective cohort study   Medical record                      Registration data                             DSM-IV
  O\'Leary, C \[[@pone.0153655.ref022]\](Aboriginal births)       2013   Australia     7760/15762             0--6               Retrospective cohort study   Medical record                      Registration data                             DSM-IV
  Langridge, AT\[[@pone.0153655.ref008]\]                         2013   Australia     4576/376539            0--6               Retrospective cohort study   Medical Record; Birth Certificate   Registration data                             DSM-IIIR/ IV/ IV-TR
  Griffith, MI\[[@pone.0153655.ref009]\]                          2011   USA           1636/79230             5--11              Retrospective cohort study   Medical Record; Birth Certificate   Registration data                             ICD9
  Mann, JR\[[@pone.0153655.ref010]\]                              2012   USA           5780/159531            3--6               Retrospective cohort study   Medical Record; Birth Certificate   Registration data                             ICD9
  Mann, JR\[[@pone.0153655.ref023]\]                              2009   USA           5388/129208            2--12              Retrospective cohort study   Medical Record; Birth Certificate   Registration data                             ICD9
  Leonard, H\[[@pone.0153655.ref012]\]                            2006   Australia     2674/236964            7--16              Retrospective cohort study   Medical record                      Registration data                             DSM-IV
  Croen, LA\[[@pone.0153655.ref024]\]                             2001   USA           11114/4590333          0--12              Retrospective cohort study   Birth Certificate                   Registration data                             ICD9
  Drews, CD\[[@pone.0153655.ref025]\]                             1996   USA           221/400                10                 Case-control study           Children\'s mother report           Registration data;School and health records   IQ≤70
  Drews, CD\[[@pone.0153655.ref026]\]                             1995   USA           316/563                10                 Case-control study           Birth Certificate                   Registration data;School and health records   IQ≤70
  Decoufle, F\[[@pone.0153655.ref027]\]                           1995   USA           314/562                10                 Case-control study           Birth Certificate                   Registration data;School and health records   IQ≤70
  Yeargin-Allsopp, M\[[@pone.0153655.ref028]\]                    1995   USA           330/563                10                 Case-control study           Birth Certificate                   Registration data;School and health records   IQ≤70
  McDermott, S\[[@pone.0153655.ref029]\]                          1993   USA           195/3098               5/9-10             Case-control study           Cildren\'s mother report            Registration data                             Raven Progressive Matrices score≤70
  Roeleveld, N\[[@pone.0153655.ref030]\]                          1992   Netherlands   306/322                0--15              Case-control study           Medical Record                      Medicaid Record;Registration data             ICD

Abbreviation:

ICD, International Classification of Diseases;

DSM: The Diagnostic and Statistical Manual of Mental Disorders;

IQ, Intelligence Quotient.

Quality of the included studies {#sec013}
-------------------------------

The methodological quality scores of the included studies ranged from four to seven points. The appraisal details are presented in [S1](#pone.0153655.s003){ref-type="supplementary-material"} and [S2](#pone.0153655.s004){ref-type="supplementary-material"} Tables. Ten of the 17 studies had scores of more than five points and were considered high quality. Variations in methodological quality may reflect in part the disproportionate inclusion of low-income families in some cohort studies\[[@pone.0153655.ref009], [@pone.0153655.ref010], [@pone.0153655.ref021], [@pone.0153655.ref023], [@pone.0153655.ref024]\] owing to the participation of these families in health insurance programs; consequently, middle- and upper-income families may have been underrepresented. In some case-control studies\[[@pone.0153655.ref025]--[@pone.0153655.ref029], [@pone.0153655.ref031]\], ID was only defined as intelligence quotient (IQ) ≤70, rather than via the diagnostic criteria of the International Classification of Diseases or the Diagnostic and Statistical Manual of Mental Disorders. Moreover, because ID can begin before the age of 18 years, the follow-up time was insufficient in most cohort studies.

Prenatal, perinatal and neonatal risk factors {#sec014}
---------------------------------------------

Tables [2](#pone.0153655.t002){ref-type="table"}--[4](#pone.0153655.t004){ref-type="table"} list the prenatal, perinatal, and neonatal risk factors included in the meta-analysis, as well as the summary effect estimate (ORs) with 95% CI and the P-value for each factor.

10.1371/journal.pone.0153655.t002

###### Meta-analysis of prenatal risk factors for ID.

![](pone.0153655.t002){#pone.0153655.t002g}

  Risk factor                                  Authors                No. of case/total   OR (95% CI)            P-value[\*](#t002fn001){ref-type="table-fn"}   P~Het~
  -------------------------------------------- ---------------------- ------------------- ---------------------- ---------------------------------------------- ---------
                                               Bilder 2013            29/2086                                                                                   
                                               Mann 2012              209/3583                                                                                  
  Advanced maternal age (≥35 vs.\<35)          Mann 2009              51/2213             **1.53(1.35, 1.72)**   **\<0.001**                                    0.03
                                               Croen 2001             1420/504751                                                                               
                                               Williams 1999          26/50                                                                                     
                                               Drews 1996             32/112                                                                                    
  Advanced maternal age (≥30 vs.\<30)          Drews 1995             NR                  0.81(0.62, 1.05)       0.11                                           0.57
                                               Yeargin-Allsopp 1995   53/152                                                                                    
                                               Bilder 2013            19/2266                                                                                   
                                               Mann 2009              10/906                                                                                    
  Maternal age\<20                             Williams 1999          132/256             1.15(0.98, 1.35)       0.09                                           0.2
                                               Drews 1996             60/129                                                                                    
                                               Drews 1995             NR                                                                                        
                                               Yeargin-Allsopp 1995   86/204                                                                                    
                                               Onicescu 2014          1443/38204                                                                                
                                               Mann 2013              2892/81230                                                                                
                                               Mann 2012              321/4873                                                                                  
  Maternal black race                          Croen 2001             1650/367611         **1.08(1.04, 1.13)**   **\<0.001**                                    \<0.001
                                               Williams 1999          356/624                                                                                   
                                               Drews 1996             170/351                                                                                   
                                               Drews 1995             NR                                                                                        
                                               Yeargin-Allsopp 1995   232/499                                                                                   
                                               Mann 2013              2399/60184                                                                                
                                               Mann 2012              1312/29950                                                                                
                                               Griffith 2011          749/31988                                                                                 
                                               Mann 2009              2247/47540                                                                                
  Low maternal education (\<12 vs.≥12 years)   Williams 1999          439/848             **1.33(1.28, 1.37)**   **\<0.001**                                    \<0.001
                                               Drews 1996             121/198                                                                                   
                                               Drews 1995             NR                                                                                        
                                               Decoufle 1995          176/332                                                                                   
                                               Yeargin-Allsopp 1995   177/333                                                                                   

**\***: Significant positive results (P\<0.05).

NR, Not Report.

10.1371/journal.pone.0153655.t003

###### Meta-analysis of prenatal risk factors for ID (Continued).

![](pone.0153655.t003){#pone.0153655.t003g}

  Risk factor                                      Authors                                 No. of case/total   OR (95% CI)            P-value[\*](#t003fn001){ref-type="table-fn"}   P~Het~
  ------------------------------------------------ --------------------------------------- ------------------- ---------------------- ---------------------------------------------- ---------
                                                   Croen 2001                              3258/1412612                                                                              
  Parity = 2 (2 vs.1)                              Drews 1996                              71/236              1.11(0.96, 1.28)       0.15                                           0.49
                                                   Drews 1995                              NR                                                                                        
                                                   Yeargin-Allsopp 1995                    95/307                                                                                    
                                                   Croen 2001                              4148/1347012                                                                              
  Parity≥3 (≥3 vs.1)                               Drews 1996                              79/158              **1.63(1.45, 1.84)**   **\<0.001**                                    0.22
                                                   Drews 1995                              NR                                                                                        
                                                   Yeargin-Allsopp 1995                    119/238                                                                                   
                                                   Onicescu 2014                           8/85                                                                                      
                                                   O\'leary 2013 (Non-Aboriginal births)   265/676                                                                                   
  Maternal alcohol use                             O\'leary 2013 (Aboriginal births)       358/811             **1.63(1.49, 1.78)**   **\<0.001**                                    0.02
                                                   Mann 2009                               68/1116                                                                                   
                                                   Drews 1996                              39/104                                                                                    
                                                   Roeleveld 1992                          204/383                                                                                   
                                                   Onicescu 2014                           77/1180                                                                                   
                                                   Mann 2013                               1177/30392                                                                                
                                                   Bilder 2013                             13/1389                                                                                   
  Maternal tobacco use                             Mann 2012                               629/14503           **1.10(1.06, 1.15)**   **\<0.001**                                    0.53
                                                   Mann 2009                               1089/27169                                                                                
                                                   Drews 1996                              221/400                                                                                   
                                                   Roeleveld 1992                          154/308                                                                                   
                                                   Langridge 2013                          NR                                                                                        
  Maternal diabetes                                Mann 2013                               734/17988           **1.15(1.08, 1.23)**   **\<0.001**                                    0.01
                                                   Mann 2012                               420/9784                                                                                  
                                                   Leonard 2006                            47/2680                                                                                   
                                                   Bilder 2013                             6/654                                                                                     
                                                   Langridge 2013                          NR                                                                                        
  Maternal hypertension /pre-eclampsia/eclampsia   Griffith 2011                           155/5169            **1.33(1.24, 1,42)**   **\<0.001**                                    \<0.001
                                                   Mann 2012                               523/11416                                                                                 
                                                   Leonard 2006                            17/1379                                                                                   
  Maternal epilepsy                                Mann 2012                               29/333              **2.76(2.16, 3.52)**   **\<0.001**                                    0.03
                                                   Leonard 2006                            42/1147                                                                                   
  Maternal asthma                                  Langridge 2013                          NR                  **1.48(1.24, 1.75)**   **\<0.001**                                    0.75
                                                   Leonard 2006                            126/7743                                                                                  

**\***: Significant positive results (P\<0.05).

NR, Not Report.

10.1371/journal.pone.0153655.t004

###### Meta-analysis of peri- and neonatal risk factors for ID.

![](pone.0153655.t004){#pone.0153655.t004g}

  Risk factor                            Authors                No. of case/total   OR (95% CI)            P-value[\*](#t004fn001){ref-type="table-fn"}   P~Het~
  -------------------------------------- ---------------------- ------------------- ---------------------- ---------------------------------------------- ---------
  Preterm birth (GA\<37 vs.≥37 weeks)    Bilder 2013            32/1359             **2.03(1.79, 2.31)**   **\<0.001**                                    0.06
                                         Griffith 2011          NR                                                                                        
                                         Onicescu 2014          284/3713                                                                                  
                                         Langridge 2013         NR                                                                                        
                                         Mann 2013              4028/83485                                                                                
                                         Mann 2012              2141/39669                                                                                
                                         Griffith 2011          1106/1174                                                                                 
  Male sex                               Croen 2001             7027/2350287        **1.96(1.90, 2.01)**   **\<0.001**                                    \<0.001
                                         Mann 2009              3620/68610                                                                                
                                         Williams 1999          289/566                                                                                   
                                         Drews 1996             138/333                                                                                   
                                         Drews 1995             NR                                                                                        
                                         Yeargin-Allsopp 1995   199/466                                                                                   
                                         Bilder 2013            30/868                                                                                    
                                         Griffith 2011          349/7667                                                                                  
  Low birth weight (\<2500g vs.≥2500g)   Croen 2001             8537/4314859        **3.56(3.27, 3.89)**   **\<0.001**                                    \<0.001
                                         Drews 1996             39/73                                                                                     
                                         McDermott 1993         195/3293                                                                                  

**\***: Significant positive results (P\<0.05).

NR, Not Report.

The statistically significant prenatal risk factors identified in the meta-analysis were as follows: advanced maternal age (maternal age over 35) (OR, 1.54; 95% CI, 1.21 to 1.96), maternal black race (OR, 1.71; 95% CI, 1.33 to 2.20), low maternal education (OR, 2.09; 95% CI, 1.73 to 2.52), third or more parity (OR, 1.63; 95% CI, 1.45 to 1.84), maternal alcohol use (OR, 1.54; 95% CI, 1.30 to 1. 83), maternal tobacco use (OR, 1.10; 95% CI, 1.06 to 1.15), maternal diabetes (OR, 1.19; 95% CI, 1.00 to 1.41), maternal hypertension (OR, 1.28; 95% CI, 1.01 to 1.64), maternal epilepsy (OR, 2.63; 95% CI, 1.54 to 4.49) and maternal asthma (OR, 1.48; 95% CI, 1.24 to 1.75) ([Table 2](#pone.0153655.t002){ref-type="table"}). There was heterogeneity among the individual studies for most outcomes excepting those for third or more parity (I^2^ = 32%, P = 0.22), maternal tobacco use (I^2^ = 0%, P = 0.53), and maternal asthma (I^2^ = 0%, P = 0.75) ([Table 2](#pone.0153655.t002){ref-type="table"}).

Significant positive associations were also found between ID risk and preterm birth (a prenatal factor) (OR, 2.50; 95% CI, 1.38 to 4.53) and between ID risk and two neonatal factors: male sex (OR, 1.84; 95% CI, 1.64 to 2.07) and low birth weight (OR, 3.43; 95% CI, 2.25 to 5.32) ([Table 3](#pone.0153655.t003){ref-type="table"}). Individual studies were heterogeneous for both neonatal outcomes (I^2^ = 93%, P \<0.0001 for both) ([Table 3](#pone.0153655.t003){ref-type="table"}).

Publication bias {#sec015}
----------------

Publication bias was assessed for the factors examined in the pooled analysis of more than two studies (Figs [2](#pone.0153655.g002){ref-type="fig"} and [3](#pone.0153655.g003){ref-type="fig"}). Significant publication bias was found for maternal black race (Begg's test, P = 0.048; Egger's test, P = 0.006) and low maternal education (Begg's test, P = 0.022; Egger's test, P \<0.001).

![Funnel plot for publication bias test.\
The two oblique lines indicate the pseudo 95% confidence limits.](pone.0153655.g002){#pone.0153655.g002}

![Funnel plot for publication bias test (Continued).\
The two oblique lines indicate the pseudo 95% confidence limits.](pone.0153655.g003){#pone.0153655.g003}

Discussion {#sec016}
==========

Identifying patients with a high risk of non-genetic ID is important for early detection and intervention of ID, which would benefit both clinical practice and public health. To our knowledge, this study is the first systemic review and meta-analysis of the relationship between prenatal, perinatal, and neonatal factors and the risk of ID. This meta-analysis included 17 cohort or case-control studies with a total of 55,344 patients and 5,723,749 control individuals.

The factors strongly associated with ID risk were advanced maternal age (\>35 years), maternal black race, low maternal education, third or more parity, maternal alcohol use, maternal epilepsy, preterm birth, male sex, and low birth weight. Other significant factors with a lower strength of association (risk estimates less than 1.5) were maternal tobacco use, maternal diabetes, maternal hypertension and maternal asthma.

The fetus is highly susceptible to changes in maternal conditions. Risk factors such as maternal toxicant exposure and metabolic disorders can significantly affect the genetically programmed brain development of the fetus. Previous studies have shown that maternal tobacco exposure\[[@pone.0153655.ref032]\], alcohol exposure\[[@pone.0153655.ref033]\], diabetes\[[@pone.0153655.ref034]\] and hypertension\[[@pone.0153655.ref035]\] can result in abnormal brain development. These risk factors are therefore closely associated with intelligence development, as indicated by our meta-analysis. What's more, Mann et al. have demonstrated that pre-pregnancy obesity contributes to maternal metabolic disorders, and is also associated with significantly increased risk of ID in the children\[[@pone.0153655.ref021]\]. Therefore, more epidemiological studies in a variety of geographic groups are needed in the future to test the consistency and generalisability of this association.

Before the 21st century, advanced maternal age was considered to be \>30 years. Several studies during that period investigated but could not confirm a relationship between maternal age and risk of ID owing to insignificant results\[[@pone.0153655.ref025], [@pone.0153655.ref026], [@pone.0153655.ref028]\]. In recent years, the maternal age at delivery has increased, and advanced maternal age has been redefined as \>35 years. Our meta-analysis demonstrates a positive association between maternal age \>35 years and the risk of ID. The father's age at the time the of child's birth is also increasing, and has been shown to correlate with ID risk\[[@pone.0153655.ref030]\]. However, most studies in our meta-analysis did not exclude the potential effects of this confounder. Further well-adjusted studies are needed and should explore the other cut-off criteria besides age over 35-year-old.

There were no significant associations between ID risk and young maternal age (under 20-year-old) or second parity. The reason may be the limited number of included studies and insufficient simple size. Young maternal age often indicates a low education level, which is also related to ID risk. However, some of the studies included in our meta-analysis did not control this confounder. Moreover, since young maternal age ranges from 16 to 20 years old\[[@pone.0153655.ref036], [@pone.0153655.ref037]\], a more extensive age range should be taken into consideration in future investigations of ID risk.

Two previous meta-analyses examined the relationship between IQ score and preterm birth\[[@pone.0153655.ref038], [@pone.0153655.ref039]\]. Both reported significantly lower IQ scores in preterm as compared with full-term infants, which is consistent with our results. In addition, Kerr-Wilson et al. reported a linear dose-response relationship between the IQ score and the gestation period: the IQ score decreased steadily for each 1-week decrease in the gestation period\[[@pone.0153655.ref038]\]. Similarly, it is worthwhile to determine whether this relationship exists even in ID cases with different severity levels. Therefore, further studies should be performed to investigate the associations between different gestational weeks and the severity of ID in preterm infants.

Some limitations of this meta-analysis should be addressed. First, several studies presented only crude ORs and did not adjust for other potential confounders, which might have resulted in overestimation of the association between risk factors and ID. Second, the heterogeneity among studies was noted in most risk factors. This heterogeneity resulted from the different diagnostic criteria of ID, age of diagnosis, sample size, and exposure or outcome assessment methods among studies. Moreover, the number of studies in each meta-analysis limited our ability to investigate these factors. Third, only published data were included in this analysis.

Conclusions {#sec017}
===========

This systemic review and meta-analysis identified prenatal, perinatal and neonatal risk factors for ID. The findings of this study indicate that prenatal factors have been the focus for studies on ID risk. In the future, more studies that focus on perinatal and neonatal factors are required, and researchers should be encouraged to investigate combinations of factors to a further study on the mechanisms leading to ID.

Supporting Information {#sec018}
======================

###### PRISMA checklist.

(DOC)

###### 

Click here for additional data file.

###### Reasons for Exclusion.

(DOCX)

###### 

Click here for additional data file.

###### New Castle Ottawa (NOS) quality assessment for cohort studies.

(XLSX)

###### 

Click here for additional data file.

###### New Castle Ottawa (NOS) quality assessment for case-control studies.

(XLSX)

###### 

Click here for additional data file.

This work was supported by the National Science Foundation of China (No.81330016, 81300524, 81172174, 81270724 and 81200462), grants from the State Commission of Science Technology of China (2013CB967404, 2012BAI04B04), grants from the Ministry of Education of China (IRT0935, 313037), grants from the Science and Technology Bureau of Sichuan province (2014SZ0149), and a grant of clinical discipline program (neonatology) from the Ministry of Health of China (1311200003303).

[^1]: **Competing Interests:**The authors have declared that no competing interests exist.

[^2]: Conceived and designed the experiments: JH DM. Performed the experiments: JH TZ. Analyzed the data: JH. Contributed reagents/materials/analysis tools: JH. Wrote the paper: JH TZ. Contributed to the critical review and final approval of the submitted manuscript: YQ DM.
